XML 17 R6.htm IDEA: XBRL DOCUMENT v3.24.2.u1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Millions
 6 Months Ended
Jun. 30, 2024
Jun. 30, 2023
Cash flows from operating activities:    
Net loss $ (70.3) $ (173.4)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 11.5 9.5
Stock–based compensation expense 20.3 32.8
Fair value adjustments 1.9 3.7
Impairment and restructuring charges 3.3 0.0
Other non-cash items (4.6) (4.8)
Changes in assets and liabilities:    
Accounts receivable, net (22.2) (41.0)
Reinsurance recoverable on paid and unpaid losses and LAE (9.5) (46.7)
Ceding commissions receivable (7.9) (24.3)
Prepaid reinsurance premiums 44.3 (65.4)
Other assets (6.1) (2.7)
Provision for commission 6.6 7.7
Accrued expenses and other liabilities (4.5) 8.3
Loss and loss adjustment expense reserves 24.4 73.8
Unearned premiums 33.5 81.8
Reinsurance premiums payable (13.6) 95.7
Net cash provided by (used in) operating activities 7.1 (45.0)
Cash flows from investing activities:    
Capitalized internal use software costs (7.0) (8.5)
Purchases of property and equipment (0.2) (29.0)
Purchases of fixed maturities (24.0) (22.1)
Maturities of fixed maturities 18.2 4.3
Sales of fixed maturities 1.4 3.2
Purchases of short-term investments (114.8) (185.1)
Maturities of short-term investments 156.6 260.1
Sales of short-term investments 0.2 26.8
Other 0.0 (0.9)
Net cash provided by investing activities 30.4 48.8
Cash flows from financing activities:    
Taxes paid related to net share settlement of equity awards (3.8) (2.9)
Proceeds from issuance of common stock 2.2 1.9
Share repurchases under program 0.0 (1.8)
Payments of contingent consideration (0.5) (0.7)
Distributions to noncontrolling interests and other (10.3) (6.4)
Net cash used in financing activities (12.4) (9.9)
Net increase (decrease) in cash, cash equivalents, and restricted cash 25.1 (6.1)
Cash, cash equivalents, and restricted cash at the beginning of the period 195.1 244.5
Cash, cash equivalents, and restricted cash at the end of the period $ 220.2 $ 238.4